Abstract Through a large-scale case-control association study using 52,608 haplotype-based single nucleotide polymorphism (SNP) markers, we identified a susceptible locus for myocardial infarction (MI) on chromosome 22q12.1. Following linkage disequilibrium (LD) mapping, haplotype analyses revealed that six SNPs in this locus, all of which were in complete LD, showed markedly significant association with MI (v 2 = 25.27, P=0.0000005; comparison of allele frequency, 3,435 affected individuals versus 3,774 controls, in the case of intron 1 5,338 C>T; rs2331291). Within this locus, we isolated a complete cDNA of a novel gene, designated myocardial infarction associated transcript (MIAT). MIAT has five exons, and in vitro translation assay showed that MIAT did not encode any translational product, indicating that this is likely to be a functional RNA. In vitro functional analyses revealed that the minor variant of one SNP in exon 5 increased transcriptional level of the novel gene. Moreover, unidentified nuclear protein(s) bound more intensely to risk allele than non-risk allele. These results indicate that the altered expression of MIAT by the SNP may play some role in the pathogenesis of MI.
Introduction
Coronary artery diseases (CAD) including myocardial infarction (MI) have been the major cause of mortality and morbidity among late-onset diseases in many industrialized countries with a Western lifestyle (Breslow 1997; Braunwald 1997) . MI often occurs without any preceding clinical signs, and is followed by severe complications, especially ventricular fibrillation and cardiac rupture which result in sudden death. Although recent advances in the treatment and diagnosis of MI have improved the quality of life for MI patients, its morbidity is still high.
Epidemiological studies revealed a variety of coronary risk factors, including type 2 diabetes mellitus, hypercholesterolemia, hypertension, and obesity. There are also studies reporting a genetic factor of this disorder; one reported first-degree relatives of patients who have had an acute MI prior to age 55 years have 2-7 times higher risk of MI (Lusis et al. 2004) . A twin study indicated an eight-fold increase in risk of death from MI when a first twin dies of MI before age 55 years (Marenberg et al. 1994) . In this context, common genetic variants are considered to contribute to genetic risks of common diseases (Lander 1996; Risch and Merikangas 1996; Collins et al. 1997) .
To date, various genetic variants that confer susceptibility to MI have been indicated to be present on several chromosomal loci through linkage analyses or case-control association studies using single nucleotide polymorphism (SNP) (Topol et al. 2001; Yamada et al. 2002; Ozaki et al. 2002 Ozaki et al. , 2004 Ozaki et al. , 2006 Stenina et al. 2003; Helgadottir et al. 2004) . Case-control association study by means of genome-wide SNP analysis is one of the most powerful approaches to identify genetic variants susceptibility to common diseases.
We report here identification of SNPs in myocardial infarction associated transcript (MIAT) that were associated with MI through our comprehensive SNP association study. We also demonstrated the possible transcriptional effect of this variation on the expression level of MIAT.
Materials and methods

DNA samples
This study included 3,464 Japanese individuals with myocardial infarction who were referred to Osaka Acute Coronary Insufficiency Study Group, which involved the cardiovascular units of 25 hospitals in Osaka. The diagnosis of definite myocardial infarction has been previously described (Ohnishi et al. 2000; Ozaki et al. 2002) . The control individuals consisted of 3,819 members of the general population who were recruited through several medical institutes in Japan. DNAs were prepared from these samples according to standard protocols. All individuals were Japanese, gave written informed consent to participate in the study, or their parents gave them when they were under 20 years old, according to the process approved by the relevant Ethical Committee at SNP Research Center, The Institute of Physical and Chemical Research (RIKEN) Yokohama.
SNP discovery and genotyping
Protocols for PCR primers, PCR experiments, DNA extraction, DNA sequencing and genotyping of SNPs have been previously described (Iida et al. 2001) . For SNP discovery, genomic DNAs from 24 Japanese individuals were used, and direct sequencing was performed using capillary sequencer (ABI3700; Applied Biosystems, Foster City, Calif., USA).
Statistical analysis
We assessed association and Hardy-Weinberg equilibrium by v 2 -test Ozaki et al. 2002) . Haplotype block and haplotype frequencies were estimated using SNPAlyze software (DYNA-COM, Chiba, Japan) and Haploview v3.2 (Barrett et al. 2005) .
Northern blot analysis
Human multiple-tissue Northern (MTN) blots (Clontech, Palo Alto, Calif., USA) were pre-hybridized and hybridized with a-[
32 P]-dCTP labeled cDNA fragment prepared by PCR using primer pair shown in Table 1 , as a probe. Washed membranes were autoradiographed for 7 days at -80°C.
Isolation of full-length cDNA A human fetal brain cDNA library was constructed with combination of gene specific linker primers, random hexamer linker primer and oligo(dT) linker primer using ZAP cDNA synthesis kit (Stratagene, La Jolla, Calif., USA) according to the manufacturer's protocol. The library was screened with the same probe as Northern experiment. Positive clones were selected and their insert cDNAs were excised in vivo in pBluescriptIISK(-) (Stratagene) according to the manufacturer's protocol. To obtain the missing 5¢-or 3¢-portion, we performed a rapid amplification of cDNA ends (RACE) using BD SMART RACE cDNA Amplification Kit (Clontech) according to the manufacturer's instructions. Primers for full-length cDNA isolation were shown in Table 1 .
In vitro translation assay
Four kinds of plasmids corresponding to variant 1-4, which were obtained through screening of ZAP human fetal brain cDNA library for isolation of MIAT full-length cDNA, were transcribed and translated using TNT T7 Quick Coupled Transcription/Translation Systems (Promega, Madison, USA) and Transcend Biotin-Lysyl-tRNA (Promega) according to the manufacturer's protocols. For negative control experiments, the antisense plasmids were constructed by inserting each PCR-amplified variant product in the opposite direction to pBluescript SK(+). Primers for constructing of the antisense plasmids were shown in Table 1 . After SDS-PAGE and electro-blotting, the biotinylated products were visualized using the Transcend Nonradioactive Translation Detection Systems (Promega).
Luciferase assay
To investigate functions of six SNPs, we cloned genomic fragments into pGL3-promoter vector (Promega) in the 5¢-3¢ orientation. For intron 1 5,338 C>T and exon 5 11,093 G>A SNPs, each PCR-amplified product was used to be cloned into each of the vectors; for two SNPs in exon 3, one single PCR-amplified product containing both of the SNP loci was used; for exon 5 11,741 G>A and exon 5 12,311 C>T SNPs, double stranded oligonucleotides was cloned into pGL3-promoter vector. Primers and oligonucleotides for cloning of luciferase construct were shown in Table 1 . We grew HEK293 cells (RIKEN Cell Bank, Wako, Japan) in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. We then performed luciferase assay according to the manufacturer's protocol. After 24 h of the transfection, we lysed the cells in passive lysis buffer (Promega) and then measured luciferase activity using the Dual-Luciferase Reporter Assay System (Promega).
Electrophoretic mobility-shift assay (EMSA)
We prepared nuclear extract from HEK293 cells as previously described (Andrews and Faller 1991) and then incubated it with 33-bp oligonucleotides labeled with digoxigenin-11-ddUTP using the Dig Gel Shift Kit, second generation (Roche, Mannheim, Germany). The oligonucleotides used in EMSA experiments were shown in Table 1 . The reaction was done with 1/10 volume of Poly [d(I-C)]. For competition studies, we pre-incubated nuclear extract with unlabeled oligonucleotides (200-fold excess) before adding digoxigeninlabeled oligonucleotide. We separated the protein-DNA complexes on a non-denaturing 6% polyacrylamide gel in 0.5· Tris-Borate-EDTA buffer. We transferred the gel to nitrocellulose membrane and detected the signal with a chemiluminescent detection system (Roche) according to the manufacturer's instructions.
In vitro RNA stability assay First, we genotyped five SNP loci using DNAs extracted from 20 different human B cell lines (HEV cell lines; RIKEN cell bank). For further RNA stability assay, we used one cell line that was heterozygous for all of these SNPs. Two DNA fragments, corresponding to nt 956-1,827 and nt 1,975-3,400 of MIAT variant 4 (GenBank accession number; AB_263417) were amplified by PCR and used as a template. These fragments were cloned into a pBlueScript II SK(+) in the 5¢-3¢ orientation. We purified the vectors and performed transcription reaction using MEGAscript high yield transcription kit (T3 kit) (Ambion) according to the manufacturer's instruction. Using 3 ll of the transcription products and 3 ll of HEK293 cell extracts (diluted 20-folds with distilled water), we performed RNA stability assay as described previously (Suzuki et al. 2003) .
Results
Large-scale SNP association study
We performed a large scale case-control association study using 188 MI patients and 752 general Japanese population by our high-throughput multiplex PCR-Invader assay method for 52,608 gene-based SNPs selected from the JSNP database on the basis of the haplotype block structure reported previously (Haga et al. 2002; Tsunoda et al. 2004 ).
Detailed screening strategy and results will be described elsewhere (Ebana et al., in preparation) . From this first-stage screening, we identified one SNP (rs2301523) in FLJ25967 (GenBank accession number, AK098833) on chromosome 22q12.1 to reveal a significant association with MI (P=0.0006). Further investigation of this SNP using a total of 3,464 MI patients and 3,819 general population confirmed the association with MI with a v 2 value of 22.71 (P=0.0000019; comparison of allele frequency) and odds ratio of 1.36 (95% confidence interval (CI); 1.20-1.55, Table 2 ). Fig. 1 , the transcript of approximately 10 kb in length was detected in spleen, peripheral blood leukocyte, lung, liver, thymus, colon and small intestine, although predominant signals were detected in fetal brain and brain. To obtain the full-length cDNA sequence for this gene, we screened the fetal brain cDNA library and subsequently carried out 5¢-and 3¢-RACE experiments. From the results of the full-length cDNA sequences, this gene was considered to have four splicing variants (GenBank Accession number: AB263414, AB263415, AB263416, and AB263417), each consisting of 10,142, 10,016, 10,068 and 9,942 nucleotides, respectively. However, we still found no long ORF in either of the four cDNA sequences; the longest ORF we identified was 447-base long encoding 149 amino acids (Fig. 2b) . Although we compared this ORF with protein sequecnes in the public databases using the BLAST program (Altschul et al. 1990 ), we found no protein showing a significant similarity. To investigate whether the transcript was really translated into protein, we carried out in vitro translation assay for each of the four variants, but no translated product was detected (Fig. 3) , suggesting this gene encodes a functional RNA. We designated this gene MIAT, myocardial infarction associated transcript. A comparison of genomic DNA sequences in GenBank database with each of the cDNA sequences determined a genomic structure of the MIAT gene. This gene consists of five exons (Fig. 2a) and all the splice junctions were considered to conform to the basic GT/AG rule (Mount 1982; Shapiro and Senapathy 1987) .
Linkage disequilibrium and haplotype analysis
To search for the possibility that another SNP(s) in this locus confers risk of MI, we investigated SNPs in this region thoroughly, except for the regions corresponding to repetitive sequences. By direct sequencing of genomic DNA from 24 individuals in Japanese population, we identified a total of 60 SNPs, including 14 novel ones which were not registered in the dbSNP database (http://www.ncbi.nlm.nih.gov/ SNP/index.html; build 126, Table 3 ). Subsequently, we selected 35 SNPs on the basis of the following two conditions; (1) SNPs should show minor allele frequencies (MAF) >5%, and (2) only one SNP can be selected from a group of SNPs that are in perfect LD among them. Then, we genotyped 96 individuals with MI and investigated a precise haplotype structure in this region using Haploview software (http:// e ta l k id n e y F e ta l li v e r F e ta l lu n g F e ta l b ra in P a n c re a s K id n e y S k e le ta l m u s c le L iv e r L u n g P la c e n ta B ra in (w h o le ) H e a rt S p le e n T h y m u s P ro s ta te T e s ti s O v a ry S m a ll in te s ti n e C o lo n (n o m u c o s a ) P e ri p h e ra l b lo o d le u k o c y te www.hapmap.org). As shown in Fig. 4 , we identified one haplotype block including the marker SNP rs2301523, which was first identified to have an association with MI through our large-scale study. In addition, we found five SNPs (intron 1 5,338 C>T, exon 3 8,813 G>A, exon 5 11,093 G>A, exon 5 11,741 G>A, exon 5 12,311 C>T) in the block in strong linkage disequilibrium (LD) with the marker SNP. Therefore, we examined whether these five SNPs were also tightly associated with susceptibility to MI by genotyping approximately 3,400 individuals with MI and 3,700 control subjects. As shown in Table 2 , all of them showed significant associations with MI. In particular, one SNP (intron 1 5,338 C>T; rs2331291) presented the most significant association with MI (v 2 =25.27, P=0.0000005; comparison of allele frequency).
To clarify a possibility that one particular haplotype in the block confers risk of MI, we selected five tag SNPs (exon 3 8,555 T>C, exon 3 9,186 G>A, exon 5 10,804 G>A, exon 5 14,569 A>T, exon 5 15,219 C>A) that could cover 90% of haplotypes in this block. We compared frequency of haplotypes and genotypes of 652 individuals with MI and 620 control subjects using these tag SNPs. Since neither haplotypes nor four other tag SNPs showed statistical significance for the association with MI (Tables 4, 5), we considered that the first marker SNP rs2301523 and additional five SNPs showing the strong LD with it were candidate SNPs associated with MI.
We investigated relationship between patients' genotype information and clinical profiles including diabetes, hypertension, smoking, hyperlipidemia, sex, and age by one-way ANOVA and v 2 test. Since we could not find positive association for any of the coronary risk factors, age, or sex (data not shown), we concluded our findings are directly related to the pathogenesis of MI.
Luciferase and Gel-shift assay Since MIAT was considered to be a non-coding functional RNA, we investigated the functions of these SNPs by examining their effect on transcriptional regulation by luciferase assay using HEK293 cell. As shown in Fig. 5d , the clone containing a G allele at position 11,741 in exon 5 had approximately 1.3-fold greater transcriptional activity than an A allele or the vector only. However, the remaining five SNPs did not show statistical difference in their transcriptional activity (P>0.05; Fig. 5a-c, e) . Subsequently, to examine whether a nuclear factor(s) might bind to genomic sequence around the exon 5 11,741 SNP, we searched for binding motifs for known transcription factors around this SNP sequence by TFSEARCH program (http:// www.cbrc.jp/research/db/TFSEARCHJ.html) based on the TRANSFAC database (Heinemeyer et al. 1998) . Although no motif for binding of the transcriptional factors was predicted, we attempted to examine binding of some nuclear factor(s) in nuclear extract from HEK293 cells to oligonucleotides corresponding to the 11,741 G and 11,741 A alleles, respectively. As shown in Fig. 5f , the A-allele oligonucleotide bound more tightly to some nuclear factor present in HEK293 cells than the G-allele oligonucleotide.
V a r i a n t -1 V a r i a n t -1 a n t i s e n s e V a r i a n t -2 a n t i s e n s e V a r i a n t -2 P o s i t i v e c o n t r o l V a r i a n t -3 a n t i s e n s e V a r i a n t - V a r i a n t -4 a n t i s e n s e V a r i a n t -4 P o s i t i v e c o n t r o l KD KD Fig. 3 In vitro translation assay The arrows indicate the bands for positive controls Effect of SNP on RNA stability
In two previous studies, SNPs and haplotypes in exons have been implicated in having some roles in the stability of mRNA (Suzuki et al. 2003; Yang et al. 2003) . To examine a possibility that the five exonic SNPs showing the significant association with MI (exon 3 8,813 G>A, exon 3 9,186 G>A, exon 5 11,093 G>A, exon 5 11,741 G>A and exon 5 112,311 C>T) might influence the stability of mRNA, we carried out RNA stability assay using HEK293 cells (Suzuki et al. 2003) . Although the mRNA corresponding to the minor haplotype tended to be degraded more rapidly as compared with that corresponding to the major one, the difference was not statistically significant (data not shown).
Discussion
Through a large scale case-control association study using gene-based genome-wide tag SNPs, we found that six SNPs in MIAT, a novel gene encoding a possible non-coding functional RNA, might confer the genetic risk of MI. Since the function of this gene was not known, it was not possible to identify this gene as associated with MI by means of candidate gene approach. An advantage of the genome-wide association without any hypothesis is to find genetic variations, even in genes encoding functional RNAs, associated with various diseases. Hence, we are confident that a comprehensive association study using genome-wide tag SNPs is a powerful tool to fully understand genetic backgrounds of common diseases. Our findings indicated that MIAT is a non-coding functional RNA. Biological functions of several noncoding functional RNAs have been investigated intensively; for example, H19 was shown to be involved in imprinting (Pfeifer et al. 1996) . Xist was the first example of the functional RNA and was proven to regulate inactivation of the X chromosome (Brown et al. 1991) . Hoxa11s is an antisense RNA for Hoxa11 and regulates transcription of Hoxa11 (Hsieh-Li et al. 1995) . Recently, Willingham et al. (2005) identified a functional long non-coding RNA (termed NRON), which acts as a repressor of the nuclear factor of activated T cell (NFAT), and showed that specific ncRNAs as NRON may play a role in regulating the complexity of intracellular trafficking. Carninci et al. (2005) found over 23,000 non-coding RNA species through comparison between full-length cDNA sequences and genome sequences, indicating the complexity of mammalian transcriptional landscape. Thus, a large number of non-coding functional RNAs seem to play important roles in a variety of biological functions. Another aspect of functional RNA is a micro RNA (miRNA), one of the sequence-specific posttranscriptional regulators of gene expression (Tang 2005) . It is generated by Dicer, a multidomain enzyme of the RNase III family. Dicer cuts precursor miRNAs with hairpin structure into miRNAs. However, sequence comparison of sense strand with antisense one using BLASTN program (Altschul et al. 1990 ) did not reveal complementary segments within MIAT, suggesting no possible hairpin structure that might give rise to double stranded RNA by Dicer. This indicates that MIAT is unlikely to contain an miRNA precursor. Although it is very difficult to reveal the function of MIAT with the present knowledge, we think the increasing attention to non-coding RNA and subsequent progress will help to solve this problem.
In the present study, we identified SNPs in MIAT conferring susceptibility to MI through a large-scale case-control association study. Although function of MIAT remains unclear, we believe that knowledge of genetic factors contributing to the pathogenesis of MI as presented here, will lead to improved diagnosis, treatment and prevention.
